Öksüzoğlu B - Search Results

1

Sevinç A, Özkan M, Özet A, Dane F, Öksüzoğlu B, Işıkdoğan A, Özdemir F, Uncu D, Gümüş M, Evrensel T, Yaren A, Kara O, Tekin SB. Sevinç A, et al. Among authors: oksuzoglu b. Onco Targets Ther. 2018 Jan 18;11:419-426. doi: 10.2147/OTT.S106342. eCollection 2018. Onco Targets Ther. 2018. PMID: 29403286 Free PMC article.

2

Primary duodenal diffuse large cell non-hodgkin lymphoma with involvement of ampulla of Vater: report of 3 cases.

Yildirim N, Oksüzoğlu B, Budakoğlu B, Vural M, Abali H, Uncu D, Zengin N. Yildirim N, et al. Among authors: oksuzoglu b. Hematology. 2005 Oct;10(5):371-4. doi: 10.1080/10245330500168773. Hematology. 2005. PMID: 16273723

3

The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma.

Ozdemir NY, Abali H, Oksüzoğlu B, Budakoglu B, Uncu D, Güler T, Odabaşi H, Zengin N. Ozdemir NY, et al. Among authors: oksuzoglu b. Med Oncol. 2010 Sep;27(3):680-4. doi: 10.1007/s12032-009-9268-y. Epub 2009 Jul 25. Med Oncol. 2010. PMID: 19633962

4

Prognostic factors and clinicopathological characteristics of carcinoma of ampulla Vateri.

Pamukcuoglu M, Oksuzoglu B, Abali H, Akoglu M, Atalay F, Budakoglu B, Uncu D, Ozdemir NY, Guler T, Zengin N. Pamukcuoglu M, et al. Among authors: oksuzoglu b. Int Surg. 2008 Jul-Aug;93(4):214-9. Int Surg. 2008. PMID: 19731856

5

Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.

Uncu D, Ozdemir NY, Aksoy S, Abali H, Oksuzoglu BC, Budakoglu B, Yildiz R, Aslan N, Zengin N. Uncu D, et al. Among authors: oksuzoglu bc. Asian Pac J Cancer Prev. 2010;11(6):1493-7. Asian Pac J Cancer Prev. 2010. PMID: 21338186 Free article.

6

Outcome of non-metastatic male breast cancer: 118 patients.

Arslan UY, Oksüzoğlu B, Ozdemir N, Aksoy S, Alkış N, Gök A, Kaplan MA, Gümüş M, Berk V, Uncu D, Baykara M, Colak D, Uyetürk U, Türker I, Işıkdoğan A. Arslan UY, et al. Among authors: oksuzoglu b. Med Oncol. 2012 Jun;29(2):554-60. doi: 10.1007/s12032-011-9978-9. Epub 2011 May 15. Med Oncol. 2012. PMID: 21573973

7

Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer.

Kos FT, Uncu D, Ozdemir N, Budakoglu B, Odabaş H, Abali H, Oksuzoglu B, Aksoy S, Zengin N. Kos FT, et al. Among authors: oksuzoglu b. Chemotherapy. 2011;57(3):230-5. doi: 10.1159/000327840. Epub 2011 May 18. Chemotherapy. 2011. PMID: 21597287

8

First-line therapy for metastatic colorectal carcinoma: modified FOLFOX4 or FOLFIRI-bevacizumab.

Odabas H, Ozdemir N, Abali H, Oksuzoglu B, Isik M, Uncu D, Cihan S, Seker M, Zengin N. Odabas H, et al. Among authors: oksuzoglu b. J BUON. 2011 Apr-Jun;16(2):247-52. J BUON. 2011. PMID: 21766493

9

Adjuvant modified FOLFOX-4 in patients with stage III rectum adenocarcinoma.

Cihan Ş, Uncu D, Babacan NA, Özdemir N, Odabaş H, Aksoy S, Öksüzoğlu B, Zengin N. Cihan Ş, et al. Among authors: oksuzoglu b. Asian Pac J Cancer Prev. 2011;12(4):967-70. Asian Pac J Cancer Prev. 2011. PMID: 21790235 Free article.

10

Adjuvant therapy for gallbladder and bile duct cancers: retrospective comparative study.

Tugba Kos F, Aksoy S, Odabas H, Ozdemir N, Oksuzoglu B, Uncu D, Zengin N. Tugba Kos F, et al. Among authors: oksuzoglu b. J BUON. 2011 Jul-Sep;16(3):464-8. J BUON. 2011. PMID: 22006751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page